Buscar
Mostrando ítems 1-10 de 3361
Biomarkers in breast cancer
(2006)
Absence of RKIP expression is an independent prognostic biomarker for gastric cancer patients
(2013-02-01)
Gastric cancer is a leading cause of cancer-related mortality, and the presence of lymph node metastasis an important prognostic factor. Downregulation of RKIP has been associated with tumor progression and metastasis in ...
Absence of RKIP expression is an independent prognostic biomarker for gastric cancer patients
(2013-02-01)
Gastric cancer is a leading cause of cancer-related mortality, and the presence of lymph node metastasis an important prognostic factor. Downregulation of RKIP has been associated with tumor progression and metastasis in ...
The germline markers NANOS and DDX are increased in cancer stem cells and samples of prostate cancer.
(2017)
Introduction: Primary tumors of prostate cancer (PCa) are characterized by their cell heterogeneity. Cancer stem cells (CSCs) are tumor cells capable of recapitulate original tumor with their different cell populations. ...
Immunoexpression of ROCK-1 and MMP-9 as prognostic markers in breast cancer
(Elsevier B.V., 2014-01-01)
Breast cancer is the most common tumor in women and it has high mortality mainly due to the occurrence of tumor metastasis. Both the processes of cell migration and anchorage to the substrate are essential for the development ...
Molecular signature of cancer stem cells isolated from prostate carcinoma and expression of stem markers in different Gleason grades and metastasis
(2012)
Prostate cancer (PCa) is the most frequently diagnosed malignancy in men worldwide. Chemotherapy response is very poor and resistance to hormone-based treatments is frequent in advances stages. Recently, tumor-initiating ...
Molecular markers for the diagnosis of thyroid cancerMarcadores moleculares para el diagnóstico de cáncer de tiroides
(Editorial Ciencia digital Registrada en la Cámara Ecuatoriana del Libro No Afiliación 663 (Editor DrC. Efraín Velasteguí López. PhD.), 2023)
Cell culture models and pharmacological perspective for the study of breast cancer markers.
(The International Federation of Clinical Chemistry and Laboratory Medicine, 2019)